Cargando…
Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes
INTRODUCTION: Glucagon-like peptide-1 (GLP-1) attenuates the glycaemic response to small intestinal nutrient infusion in stress-induced hyperglycaemia and reduces fasting glucose concentrations in critically ill patients with type-2 diabetes. The objective of this study was to evaluate the effects o...
Autores principales: | Deane, Adam M, Summers, Matthew J, Zaknic, Antony V, Chapman, Marianne J, Fraser, Robert JL, Di Bartolomeo, Anna E, Wishart, Judith M, Horowitz, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222072/ https://www.ncbi.nlm.nih.gov/pubmed/21255422 http://dx.doi.org/10.1186/cc9983 |
Ejemplares similares
-
The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study
por: Deane, Adam M, et al.
Publicado: (2009) -
Exogenous glucagon-like peptide 1: a potentially novel therapy for the management of hyperglycaemia in the critically ill
por: Deane, A, et al.
Publicado: (2009) -
The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1 on Glycemia in the Critically Ill
por: Lee, Michael Y., et al.
Publicado: (2013) -
Comparative effects on glucose absorption of intragastric and post-pyloric nutrient delivery in the critically ill
por: Di Bartolomeo, Anna E, et al.
Publicado: (2012) -
Glucose absorption following gastric and small intestinal nutrient administration in the critically ill
por: Chapman, M, et al.
Publicado: (2011)